Armenian National Registry of Myocardial Infarction
ARMI
1 other identifier
observational
2,500
1 country
13
Brief Summary
This is a national, multicenter prospective observational study of patients presenting to hospitals in Armenia with STEMI diagnosis. The main questions it aims to answer are:
- Determine the rate of in-hospital mortality for the patients with STEMI admitted to the participating hospitals.
- Compare short and long-term CV and all-cause mortality and hospitalization.
- Determine how professional guidelines are followed in real-world situations.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2023
Typical duration for all trials
13 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 15, 2023
CompletedFirst Posted
Study publicly available on registry
September 21, 2023
CompletedStudy Start
First participant enrolled
December 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2025
CompletedDecember 26, 2023
September 1, 2023
2 years
September 15, 2023
December 22, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Rate of the in-hospital mortality
Determine the rate of the in-hospital mortality for the patients with STEMI admitted to the participating hospitals
During 5 to 7 days of hospitalization
Secondary Outcomes (2)
Cardiovascular mortality
30 days and 12 months
All-cause mortality
30 days and 12 months
Interventions
No specific intervention
Eligibility Criteria
The pre-screened population will consist of all patients \>18 years old presenting acutely with suspected STEMI in the participating hospitals. Only patients with confirmed diagnosis of STEMI will be included in the registry, after informed consent signing.
You may qualify if:
- Adult patient (≥ 18 years of age),
- Admitted to the participating centers for a STEMI within 48 hours of symptom onset: characterized by a rise and fall of cardiac markers (troponins) together with ST elevation in at least two contagious leads or LBBB.
- Have given signed informed consent to participate in the study.
- MI occurring ≤ 48 hours after PCI or CABG
- The patient or the legal representative refused to sign the informed consent
You may not qualify if:
- Withdrawal of the informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (13)
Vanadzor Medical Center
Vanadzor, Lori, Armenia
Gyumri Medical Center
Gyumri, Shirak, Armenia
French-Armenian Cardiovascular Center
Goris, Syunik, Armenia
Heratsi Hospital Complex N1
Yerevan, 0025, Armenia
Erebouni Medical Center
Yerevan, 0087, Armenia
Aramyants Medical Center
Yerevan, Armenia
Armenia Medical Center
Yerevan, Armenia
Astghik Medical Center
Yerevan, Armenia
Best Life Medical Center
Yerevan, Armenia
Nork Marash Medical Center
Yerevan, Armenia
Shengavit Medical Center
Yerevan, Armenia
Surb Grigor Lusavorich Medical Center
Yerevan, Armenia
Yerevan Scientific Medical Center
Yerevan, Armenia
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hamlet G Hayrapetyan, Prof.
Armenian Cardiologists Association
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 12 Months
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 15, 2023
First Posted
September 21, 2023
Study Start
December 1, 2023
Primary Completion
December 1, 2025
Study Completion
December 30, 2025
Last Updated
December 26, 2023
Record last verified: 2023-09
Data Sharing
- IPD Sharing
- Will not share